Changes in prostaglandin E2 (PGE2) levels in paw exudate, stomach and kidney of arthritic rats: Effects of flosulide

Prostaglandins and Other Lipid Mediators

Volumn 66, Issue 1, 2001, Pages 27-37

  Turull, Àngels ^a   Queralt, Josep ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2 INHIBITOR; FLOSULIDE; INDOMETACIN; PROSTAGLANDIN E2; CYCLOOXYGENASE 2; INDAN DERIVATIVE; ISOENZYME; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADJUVANT ARTHRITIS; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; KIDNEY; MYCOBACTERIUM BUTYRICUM; NONHUMAN; ORGAN DISTRIBUTION; PAW EDEMA; RAT; STOMACH MUCOSA; STOMACH WALL; TISSUE LEVEL; ANIMAL; ANTIBODY SPECIFICITY; ARTHRITIS; DOSE RESPONSE; DRUG ANTAGONISM; EDEMA; FOOT; METABOLISM; STOMACH; TIME; WISTAR RAT;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOT; INDANS; INDOMETHACIN; ISOENZYMES; KIDNEY; ORGAN SPECIFICITY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; STOMACH; TIME FACTORS;

EID: 0034742263     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(01)00138-1     Document Type: Article

References (39)

1. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: Possible physiological and therapeutic implications
2. Cyclooxygenases 1 and 2
3. Development of arthritis, periarthritis and periostitis in rats given adjuvant
4. Models of arthritis and the search for anti-arthritic drugs
5. Animal models of rheumatoid arthritis. Clues to etiology and treatment
6. Assessment of plasma leukotriene and prostaglandin levels during adjuvant arthritis and kaolin-induced paw oedema in rats
7. Increased total body synthesis of prostacyclin in rats with adjuvant arthritis
8. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rats adjuvant arthritis
9. Prostaglandins: Effects on the gastrointestinal tract
10. Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach
11. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
12. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice
13. Role of cyclooxygenase-2 in the healing of gastric ulcers in rats
14. Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats
15. Effects of cyclooxygenase-2 selective and nitric-oxyde-releasing nonsteroidal anti-inflammatory drugs on mucosal ulcerogenic and healing responses of the stomach
16. Renal complications associated with use of nonsteroidal anti-inflammatory agents
17. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction
18. 2 on the induction of nitric oxide and prostanoid-forming pathways in cultured mesangial cells
19. The pharmacological profile of CGP 28,238, a novel highly potent anti-inflammatory compound
20. Selective inhibition of cyclooxygenase 2
21. Biochemical and pharmacologial profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor
22. Influence of adjuvant arthritis in main urinary metabolite of prostaglandin F and E in rats
23. Prostaglandins in the blood serum of patients with rheumatoid arthritis
24. Cyclic AMP and prostaglandin E in perfusates of rat hind paws during the development of adjuvant arthritis
25. The role of prostaglandins in experimental arthritis in the rat
26. Selective inhibition of cyclooxygenase-2 with antisense oligodeoxynucleotide restricts induction of rat adjuvant-induced arthritis
27. Alterations in the gastro-intestinal functions during the development of adjuvant disease in rats
28. The relationship between serum gastrin, gastric ulceration and basal acid output in the polyarthritic rat
29. Altered susceptibility of arthritic rats to the gastric lesion-inducing effects of aspirin or ethanol and the antilesion effect of rioprostil
30. Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats
31. Anti-inflammatory effect of FR 140423, a novel selective cyclooxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects
32. Incidence of gastric ulcers by indomethacin and piroxicam in rats
33. Reduction of adverse effects of indomethacin by anti-allergic drugs in rat stomachs
34. NSAID-induced gastric damage in rats: Requirement for inhibition of both cycloxygenase 1 and 2
35. Structural and metabolic disorders in the heart, liver and kidneys in adjuvant disease
36. Urinary N-acetyl-β-D-glucosam inidase as a marker of renal injury in adjuvant arthritis
37. Different actions of the cycloxygenase 2 selective inhibitor flosulide in rats with passive Heymann nephritis
38. Glomerular and tubular proteinuria as markers of nephropathy in rheumatoid arthritis
39. Acute effects of anti-inflammatory cyclooxygenase-2 selective inhibitor, flosulide, on renal plasma flow and glomerular filtration rate in rats